The pharmacy residency in hematology/oncology builds on experiences in the PGY1 year and is designed to provide a well-rounded experience leading to the development of expert knowledge, skills, and clinical leadership in the practice of hematology/oncology pharmacy. This 12-month program offers training opportunities through a variety of clinical rotations and interactions with multidisciplinary healthcare teams. We offer a flexible program that focuses on the goals of the resident and is intended to provide clinical, research, and teaching experience. Graduates of the program should be prepared to pursue employment as a hematology/oncology pharmacotherapy clinical specialist in the acute care setting.
The program emphasizes clinical practice with required rotations in bone marrow transplant, solid tumors, transplant infectious disease, pediatric oncology, malignant hematology, adult leukemia, benign hematology, ambulatory oncology, palliative care, and chemotherapy preparation. Elective rotations may be completed in any of required rotations for an additional four weeks. Completion of a medication usage evaluation (MUE) and research project as well as participation in the Hematology/Oncology Subcommittee and Chemotherapy Safety Committee are also required.
This residency participates in the American Society of Health-System Pharmacists Residency Matching Program and is in the process of applying for ASHP accreditation.
Applicants must have graduated from an accredited Doctor of Pharmacy (Pharm.D. program and completed an ASHP-accredited pharmacy practice residency (or equivalent experience) prior to beginning this residency. Applicants must also be eligible for licensure in New York State.
NewYork-Presbyterian Hospital Residency Programs participate in the ASHP-associated Pharmacy Online Residency Centralized Application Service (PhORCAS) for applications and the National Matching Service (NMS) for the residency matching process. Required documents should be submitted through PhORCAS by January 8th. Required documents include:
More details on the use of PhORCAS can be found at ashp.org
Paper applications may be accepted under unusual circumstances through special arrangement with the Residency Program Director.
Department of Pharmacy
525 East 68th Street, Room K-04
New York, NY 10065